Rabies Vaccine Market, By Product Type (Vero Cell Rabies Vaccine, Baby Hamster Kidney (BHK) and Chick Embryo Cell Rabies Vaccine), By Application, By Prophylaxis Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Rabies Vaccine Market size was valued at USD 1,345.43 million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.
Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations, thereby expanding the market. Ongoing research and development leading to improved vaccines with better efficacy, longer protection, and fewer side effects stimulate market demand. Increased awareness about rabies prevention and the importance of vaccination through educational campaigns positively impacts market growth. However, there are concerns over potential side effects and adverse reactions that can deter individuals from getting vaccinated.
Rabies Vaccine Market- Market Dynamics
Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations
The growing trend in pet ownership, coupled with an increasing awareness of veterinary care, underscores the importance of pet vaccinations. As more households welcome pets into their families, ensuring these animals are protected against preventable diseases becomes a top priority. Vaccines protect pets from a variety of serious and potentially fatal diseases, such as rabies, distemper, parvovirus, and feline leukemia. According to the survey, there are over 31 million pet dogs in India. Homeowners are more likely to own pets than renters: 58% of homeowners have a dog and 36% have a cat versus 39% and 29% of renters respectively. 11% of people in India own at least four pets. As pet ownership continues to rise, the emphasis on vaccinations is essential for safeguarding the health of pets and their human companions. Regular vaccinations are a vital component of responsible pet care, ensuring that pets live longer, healthier lives while also protecting public health.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RABIES VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Serum Institute of India Pvt. Ltd
Novartis AG
Cadila Pharmaceuticals
Merck & Co., Inc.
Sanofi
ADS Diagnostic Ltd
GSK plc
Berna Biotech Pharma GmbH
AstraZeneca
Others
GLOBAL RABIES VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Vero Cell Rabies Vaccine
Baby Hamster Kidney (BHK)
Chick Embryo Cell Rabies Vaccine
Others
GLOBAL RABIES VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Human
Animal
GLOBAL RABIES VACCINE MARKET, BY PROPHYLAXIS TYPE - MARKET ANALYSIS, 2019 - 2032
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
GLOBAL RABIES VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Veterinary clinics
Others
GLOBAL RABIES VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Rabies Vaccine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Rabies Vaccine Market Snippet by Product Type
2.1.2. Rabies Vaccine Market Snippet by Application
2.1.3. Rabies Vaccine Market Snippet by Prophylaxis Type
2.1.4. Rabies Vaccine Market Snippet by End User
2.1.5. Rabies Vaccine Market Snippet by Country
2.1.6. Rabies Vaccine Market Snippet by Region
2.2. Competitive Insights
3. Rabies Vaccine Key Market Trends
3.1. Rabies Vaccine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Rabies Vaccine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Rabies Vaccine Market Opportunities
3.4. Rabies Vaccine Market Future Trends
4. Rabies Vaccine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Rabies Vaccine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Rabies Vaccine Market Landscape
6.1. Rabies Vaccine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Rabies Vaccine Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
7.1.2. Vero Cell Rabies Vaccine
7.1.3. Baby Hamster Kidney (BHK)
7.1.4. Chick Embryo Cell Rabies Vaccine
7.1.5. Others
8. Rabies Vaccine Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Human
8.1.3. Animal
9. Rabies Vaccine Market – By Prophylaxis Type
9.1. Overview
9.1.1. Segment Share Analysis, By Prophylaxis Type, 2023 & 2032 (%)
9.1.2. Pre-Exposure Prophylaxis
9.1.3. Post-Exposure Prophylaxis
10. Rabies Vaccine Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
10.1.2. Hospitals
10.1.3. Veterinary clinics
10.1.4. Others
11. Rabies Vaccine Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Rabies Vaccine Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Rabies Vaccine Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Rabies Vaccine Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Rabies Vaccine Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Rabies Vaccine Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Rabies Vaccine Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Serum Institute of India Pvt. Ltd
12.2.2. Novartis AG
12.2.3. Cadila Pharmaceuticals
12.2.4. Merck & Co., Inc.
12.2.5. Sanofi
12.2.6. ADS Diagnostic Ltd
12.2.7. GSK plc
12.2.8. Berna Biotech Pharma GmbH
12.2.9. AstraZeneca
12.2.10. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
